Network pharmacology-based investigation of potential targets of astragalus membranaceous-angelica sinensis compound acting on diabetic nephropathy
Abstract To explore the mechanism of the Astragalus membranaceous (AM)-Angelica sinensis (AS) compound in the treatment of diabetic nephropathy (DN) we used network pharmacology and molecular docking. Screen the components and targets of the AM-AS compound in the TCMSP and the BATMAN-TCM, and establ...
Guardado en:
Autores principales: | Youzi Dong, Quanlin Zhao, Yuguo Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/875de4a07a344fdab67cef9205bdef48 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Full-length transcriptome analysis provides new insights into the early bolting occurrence in medicinal Angelica sinensis
por: Xue Gao, et al.
Publicado: (2021) -
Molecular authentication of the traditional Chinese medicinal plant Angelica sinensis based on internal transcribed spacer of nrDNA
por: Feng,Tu, et al.
Publicado: (2010) -
Astragalus–Saffron–Rhubarb Mixture Delays the Progress of Diabetic Nephropathy in db/db Mice
por: Zhou XC, et al.
Publicado: (2021) -
Efficiency of improved RAPD and ISSR markers in assessing genetic diversity and relationships in Angelica sinensis (Oliv.) Diels varieties of China
por: Mei,Zhiqiang, et al.
Publicado: (2015) -
Astragalus alters gut-microbiota composition in type 2 diabetes mice: clues to its pharmacology
por: Li XY, et al.
Publicado: (2019)